Company / Operating Cash Flow
Innoviva, Inc. Operating Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
$196.9M
FY2025
5-year range
$141.1M / $363.8M
FY2021-FY2025
Trend
+4.4%
vs FY2024
Sector context
#40 of 216
Health Care
What the data says
Innoviva, Inc.'s operating cash flow of $197M is higher than 81% of companies in the Health Care sector (FY2025). Operating Cash Flow has fluctuated over the past 10 years, ranging from $61M in FY2018 to $364M in FY2021.
Based on SEC 10-K filings.
$197M in FY2025 with a 5-year CAGR of -8.9%. Top quartile in the Health Care sector.
Improved from $141M to $197M over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -14.3%
- 5-Year CAGR
- -8.9%
- 10-Year CAGR
- -
Sector benchmark
-70.1% below sector average
Key checks
Key Insights
- 5-year CAGR of -8.9%, indicating a declining trend.
- In FY2025, operating cash flow increased 4.4% year-over-year.
- Ranks #40 out of 216 companies in the Health Care sector.
- Peak operating cash flow was recorded in FY2021.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $196.9M | +4.4% |
| FY2024 | $188.7M | +33.8% |
| FY2023 | $141.1M | -54.9% |
| FY2022 | $313.1M | -13.9% |
| FY2021 | $363.8M | +16.2% |
| FY2020 | $313.1M | +120.9% |
| FY2019 | $141.7M | +132.4% |
| FY2018 | $61.0M | -57.0% |
| FY2017 | $141.7M | +132.4% |
| FY2016 | $61.0M | +502.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026